A 14-year-old boy with severe erythema multiforme due to amoxicillin.

Coxsackie virus A6 drug eruption erythema multiforme lymphocyte transformation testing patch test

Journal

Asia Pacific allergy
ISSN: 2233-8276
Titre abrégé: Asia Pac Allergy
Pays: Netherlands
ID NLM: 101561954

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 21 04 2023
accepted: 11 06 2023
medline: 25 9 2023
pubmed: 25 9 2023
entrez: 25 9 2023
Statut: ppublish

Résumé

The most common cause of erythema multiforme (EM) in children is infectious diseases which account for approximately 90% of cases. Drug eruptions are another common cause. Here we are reporting about a male patient aged 14 years with lymphadenitis who developed severe diffuse erythema during the course of treatment with medications including several antibiotics and nonsteroidal anti-inflammatory drugs (NSAIDs). Based on the pathological findings of the skin biopsy, the skin rash was due to EM. Upon investigating the underlying cause of EM, viral antibody was positive for Coxsackie A6, lymphocyte transformation testing (LTT) was positive for one of the NSAIDs, and the patch test (PT) was positive for amoxicillin. Based on the pattern of distribution of the skin rash, the cause of EM was considered to be drug-induced eruption due to amoxicillin. In this case, we did not derive a diagnosis of drug eruption without investigating the possibility of drug induction, because most cases of EM in children are induced by infection and the antibody against Coxsackie A6 was elevated. To diagnose the possibility of amoxicillin-induced EM, it was important to distinguish between the distribution patterns of infectious versus drug-induced EM and to evaluate the possibility of drug induction by both LTT and PT. If the diagnosis of amoxicillin-induced EM, had not been made, the potential recurrence of EM with amoxicillin could have occurred.

Identifiants

pubmed: 37744962
doi: 10.5415/apallergy.0000000000000108
pmc: PMC10516312
doi:

Types de publication

Case Reports

Langues

eng

Pagination

135-138

Informations de copyright

Copyright © 2023. Asia Pacific Association of Allergy, Asthma and Clinical Immunology.

Déclaration de conflit d'intérêts

The authors have no financial conflicts of interest.

Références

Contact Dermatitis. 1996 Oct;35(4):234-6
pubmed: 8957644
Allergy. 2023 Sep;78(9):2529-2532
pubmed: 36951669
Int J Dermatol. 2012 Aug;51(8):889-902
pubmed: 22788803
Clin Exp Allergy. 2002 May;32(5):736-44
pubmed: 11994099
Cureus. 2018 Oct 16;10(10):e3459
pubmed: 30564538
Clin Exp Allergy. 1997 Feb;27(2):175-81
pubmed: 9061217
Pediatrics. 2018 May;141(5):
pubmed: 29700201
Clin Exp Dermatol. 2014 Apr;39(3):279-83
pubmed: 24635061
Br J Dermatol. 2013 Mar;168(3):555-62
pubmed: 23136927
Mil Med. 2020 Sep 18;185(9-10):e1847-e1850
pubmed: 32373930
JAMA. 2019 Jun 18;321(23):2367
pubmed: 31211341

Auteurs

Mami Kurihara (M)

Department of Pediatrics, Nippon Medical School Musashikosugi Hospital, Kanagawa, Japan.

Shingo Yamanishi (S)

Department of Pediatrics, Nippon Medical School Hospital, Tokyo, Japan.

Saeko Ozaki (S)

Department of Dermatology, Nippon Medical School Hospital, Tokyo, Japan.

Ruby Pawankar (R)

Department of Pediatrics, Nippon Medical School Hospital, Tokyo, Japan.

Classifications MeSH